Windt Le Grand Leeuwenburgh Advocaten

European Commission and national competition authorities are pushing back against abuse of dominance in the pharmaceutical sector and high medicine prices

On 10 February 2021 the European Commission accepted commitments offered by pharmaceutical producer Aspen for price reductions for 6 critical cancer medicines. This brought an end to the Commission’s investigation under Article 102 TFEU (abuse of a dominant position) into Aspen’s pricing practices, which it had started in 2017. The investigation concerned Aspen’s pricing policy for its medicines, which are used in the treatment of certain types of cancer such as leukaemia and other haematological cancers.

Read the full article here

Share

About this post

Date: 18 March 2021
Published on: Lexology
Publicatie EU, state aid & competition law IP & pharma
Authors
Annemarije van Nijendaal
Gerard van der Wal

Also interesting

News
12-04-23

Windt Le Grand Leeuwenburgh once again achieves rankings in The Legal 500

Windt Le Grand Leeuwenburgh once again achieves rankings in The Legal 500. The Legal 500 published its guide for Europe 2023. Five practice groups and eleven of our...

Read more
News
02-06-23

Access to justice in State aid matters in EU Member States

This week, ClientEarth published the study called ‘Access to justice in State aid matters in EU Member States – Where do NGOs stand?’...

Read more
Publication
18-03-21

Recent Dutch case law on the termination of agreements without cause

As part of transactions, parties often enter into term sheets and various types of ancillary agreements, such as consultancy or management agreements. Disputes concerning...

Read more
Publication
18-03-21

COVID-19 and Dutch filing and accounting obligations

Earlier, at the end of last year, on LinkedIn we posted the legal alert below regarding director’s liability in bankruptcy pursuant to section 2:138/248 of the...

Read more
Publication
18-03-21

Deliveroo drivers are employees

In February 2018, Deliveroo altered the relationship with its drivers in the Netherlands from an employment contract into a so-called partner agreement. However, less...

Read more
Publication
18-03-21

Is exhaustion of trademark rights a matter of fact or a matter of intention?

The French company Moet Hennessy has lodged an appeal before the Netherlands Supreme Court against a decision of the court of appeal of The Hague to the effect that Moet...

Read more
Publication
30-06-21

Every advantage has its disadvantage (and Vice Versa)

The General Court handed down a judgement in 2020 in which it annulled the Commission’s Decision regarding State aid granted to Valencia Club de Fútbol...

Read more
Publication
02-02-21

Dutch scheme: tool or trouble?

The Netherlands finally has its own state of the art restructuring law, the Dutch Scheme. What does that bring GCs? A great tool if handled with care and otherwise...

Read more